Abstract: The present invention relates to a heating plate particularly suitable for devices for heating a thermal fluid. The heat generated in this device is conveyed to other locations through the thermal fluid, where the heat is given off, for example, through a heat exchanger configured as a radiator. The heating plate is characterized by an electronics-free safety solution intended to automatically cause the generation of heat to cease when temperatures above a preestablished safety temperature are reached.

Abstract: Described herein are methods, systems, and computer-readable storage media for automated detection of attention deficit hyperactivity disorder (ADHD). Techniques include providing stimuli to a user to activate a plurality of brain regions representing an attention network by displaying information with a first condition that causes a reaction and a second condition as an exception to the first condition. Techniques further include retrieving a plurality of signals from the plurality of brain regions for each of the stimuli, wherein each signal of the plurality of signals is accessed over a period of time that starts when the information is displayed and ends when the reactions of the user are captured. Further, the attention deficit detection system evaluates the signals to detect ADHD based on the level of connectivity within the attention network when each signal of the plurality of signals corresponds to the one or more stimuli.

Abstract: The present invention relates to a communications channel adaptation method for URLLC services which is configured for ensuring reliability when implementing said URLLC services and executed in a communications system with at least one transmitter node (eNode) and a receiver or mobile terminal, wherein the receiver or mobile terminal measures the desired signal-to-interference ratio (SIR) from the reference signal received in instant t=i?1 and saves this SIR value (SIRi-1) in a memory; wherein based on this SIR value in instant t=i?1 (SIRi-1), a CQI value (CQIi-1) is determined and sent to the transmitter node (eNode), which selects the modulation and coding format in the subsequent transmission (MCSi) in the downlink according to that CQI measured in instant t=i-1 (CQIi-1); and wherein upon receiving in instant t=i the data packet sent by the transmitter node (eNode), the receiver terminal measures the SIR (SIRi) and saves it in a memory.

Abstract: The invention relates to a fusion protein comprising a polypeptide of interest, a transmembrane domain and an HIV gag polypeptide, or their functionally equivalent variants. The invention also relates to the polynucleotides, vectors, host cells and virus-like particles expressing or presenting said fusion proteins and to the pharmaceutical, immunogenic or vaccines composition containing said fusion proteins, polynucleotides, vectors, host cells and virus-like particles and their use in human and veterinary medicine.

Abstract: The invention relates to a fusion protein comprising a polypeptide of interest, a transmembrane domain and an HIV gag polypeptide, or their functionally equivalent variants. The invention also relates to the polynucleotides, vectors, host cells and virus-like particles expressing or presenting said fusion proteins and to the pharmaceutical, immunogenic or vaccines composition containing said fusion proteins, polynucleotides, vectors, host cells and virus-like particles and their use in human and veterinary medicine.

Abstract: The present invention relates to an in vitro method for determining HIV neutralizing antibodies in a sample. It further relates to a fusion protein to be used in said method and a nucleic acid encoding said fusion protein.

Abstract: The present invention relates to an in vitro method for determining HIV neutralizing antibodies in a sample. It further relates to a fusion protein to be used in said method and a nucleic acid encoding said fusion protein.

Abstract: The method and device proposed for wireless communications systems based on WCDMA technology modifies the desired signal to interference ratio target (SIRtarget) when it detects the exit from the wind-up condition in the mobile communication, that is, when the unwinding process has started, in order to match it to the outer loop power control in normal mode, setting for this desired signal to interference ratio target (SIRtarget) a value that is as close as possible to that which it had just before the moment of the start of the wind-up so that immediate afterwards it can continue with the correct variation determined by the power control in the normal mode of the outer loop. Thus, the unwinding time is shortened and the interference in the mobile communication system is reduced, while its capacity and the quality of its wireless connections are increased.

Abstract: Outer loop power control (OLPC) method and apparatus for mobile communications systems which allow rapid adjustment of the target desired signal to interference ratio (SIRtarget) satisfying a target block error rate (BLERtarget). Specifically, the outer loop power control method proposed herein is termed “Outage-Based OLPC” and establishes that the target desired signal to interference ratio (SIRtarget) is given as the sum of two components: the first component (SIRoutage-tgt) is calculated by means of a dynamic adjusting function, for example, a neural network which makes a quality criterion based on outage probabilities correspond with one based on the target block error rate (BLERtarget), taking as input the fading margins associated with the different outage probabilities considered; the other component (SIRBLER-tgt) is that which acts to correct the possible deviations in the target block error rate (BLERtarget) due to the non-ideal behavior of the previous component (SIRoutage-tgt).

Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.

Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.

Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.

Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.

Abstract: The method and device proposed for wireless communications systems based on WCDMA technology modifies the desired signal to interference ratio target (SIRtarget) when it detects the exit from the wind-up condition in the mobile communication, that is, when the unwinding process has started, in order to match it to the outer loop power control in normal mode, setting for this desired signal to interference ratio target (SIRtarget) a value that is as close as possible to that which it had just before the moment of the start of the wind-up so that immediate afterwards it can continue with the correct variation determined by the power control in the normal mode of the outer loop. Thus, the unwinding time is shortened and the interference in the mobile communication system is reduced, while its capacity and the quality of its wireless connections are increased.

Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.

Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.

Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.

Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.

Abstract: The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.